Holen Sie sich die Stockscreener-App
3.33
2.63%
-0.09
Vorhandelsmarkt:
3.32
-0.01
-0.30%
Schlusskurs vom Vortag:
$3.42
Offen:
$3.42
24-Stunden-Volumen:
287.00K
Relative Volume:
0.70
Marktkapitalisierung:
$128.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-42.05M
KGV:
-1.1809
EPS:
-2.82
Netto-Cashflow:
$-35.26M
1W Leistung:
+9.18%
1M Leistung:
+9.18%
6M Leistung:
-29.00%
1J Leistung:
+43.53%
1-Tages-Spanne:
$3.255
$3.45
1-Wochen-Bereich:
$3.06
$3.45
52-Wochen-Spanne:
$1.595
$10.48
Protara Therapeutics Inc Stock (TARA) Company Profile
Firmenname
Protara Therapeutics Inc
Sektor
Branche
Telefon
646-844-0337
Adresse
345 PARK AVENUE SOUTH, NEW YORK, NY
Vergleichen Sie TARA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TARA
Protara Therapeutics Inc
|
3.33 | 117.67M | 0 | -42.05M | -35.26M | -2.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Protara Therapeutics Inc Stock (TARA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-03-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-07-10 | Fortgesetzt | Guggenheim | Buy |
| 2021-06-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-02-17 | Eingeleitet | Oppenheimer | Outperform |
| 2020-10-19 | Eingeleitet | Cowen | Outperform |
| 2020-07-29 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Protara Therapeutics Inc Aktie (TARA) Neueste Nachrichten
What drives Protara Therapeutics Inc. stock priceUnmatched market performance - jammulinksnews.com
Is Protara Therapeutics Inc. a good long term investmentRapid growth trajectories - jammulinksnews.com
Protara Therapeutics Inc. Stock Analysis and ForecastJaw-dropping returns - jammulinksnews.com
Protara Therapeutics (NASDAQ:TARA) Shares Up 11% – Still a Buy? - Defense World
What analysts say about Protara Therapeutics Inc. stockTremendous portfolio expansion - jammulinksnews.com
Best Banking Stocks AI Stock ForecastsRapidly expanding wealth - PrintWeekIndia
What analysts say about Arvinas Inc. stockFree Stock Movement Tracking - jammulinksnews.com
Is Armada Hoffler Properties Inc. a good long term investmentExplosive earning power - jammulinksnews.com
DGICB Stock Analysis and ForecastSkyrocketing investment returns - jammulinksnews.com
Will Protara Therapeutics Inc. stock split in the near futureDaily Top Gainers - Newser
Why Protara Therapeutics Inc. stock attracts strong analyst attentionFree Capital Allocation Plans - beatles.ru
What makes Protara Therapeutics Inc. stock price move sharplyMinimized Risk Trading Plan - Newser
How Protara Therapeutics Inc. stock performs during market volatilityStable Stocks With High Yield - Newser
Protara Therapeutics Awards 44,250 Equity Grants Worth $2.80 Per Share to Strategic New Hires - Stock Titan
TARA SEC FilingsProtara Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Protara Therapeutics, Inc.(NasdaqGM: TARA) added to Russell 3000E Index - MarketScreener
Protara Therapeutics, Inc. Added to Russell 3000® Index, Enhancing Visibility in Financial Community - Nasdaq
Protara Therapeutics (TARA) Drops 3.69% to 2024 Low - AInvest
Non-Muscle Invasive Bladder Cancer Market Set to Grow Substantially Through 2034, DelveInsight Projects | CG Oncology, Pfizer, UroGen Pharma, Janssen Research & Development, LLC, Protara Therapeutics - The Globe and Mail
Why EchoStar Stock Is Soaring Higher Today - The Globe and Mail
Two Sigma Investments LP Cuts Stock Holdings in Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World
Protara Therapeutics: Marching On To A Hopefully Eventful Back Half Of 2025 (NASDAQ:TARA) - Seeking Alpha
SoundHound AI (SOUN): This High-Potential Growth Stock Could Be Your Smartest Bet under $10 - The Globe and Mail
Where Will Uber Stock Be in 5 Years? - The Globe and Mail
Company News for Jun 13, 2025 - The Globe and Mail
Protara Therapeutics: Clinical Milestones and Robust Liquidity Fuel Near-Term Upside - AInvest
Protara Therapeutics Holds Annual Stockholders Meeting - TipRanks
These 3 ‘Bro Billionaire’ Stocks Are Wildly Outperforming in Trump’s Market - The Globe and Mail
Kantar appoints Jeff Greenspoon as CEO, Americas - The Globe and Mail
Cantor Fitzgerald Forecasts TARA FY2026 Earnings - Defense World
Squarepoint Ops LLC Makes New $110,000 Investment in Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World
Steven Hudson buying at ECN Capital (ECN) - The Globe and Mail
Protara Therapeutics, Inc. (NASDAQ:TARA) Position Increased by Bank of America Corp DE - Defense World
Protara Therapeutics, Inc. (NASDAQ:TARA) Given Average Recommendation of “Buy” by Analysts - Defense World
Why Shares of Tesla Are Sinking Today - The Globe and Mail
Is Costco a Buy Now? - The Globe and Mail
Millennium Management LLC Purchases 357,051 Shares of Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World
Finanzdaten der Protara Therapeutics Inc-Aktie (TARA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):